You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

preservative

Showing 1 - 25 of 874
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Dry Eye Trial in Fort Worth (Propylene glycol solution/drops)

Not yet recruiting
  • Dry Eye
  • Propylene glycol solution/drops
  • Fort Worth, Texas
    Alcon Call Center for Trial Locations
Jun 27, 2023

Dry Eye Trial in Fort Worth (Polyethylene glycol 400 and propylene glycol solution/drops)

Not yet recruiting
  • Dry Eye
  • Polyethylene glycol 400 and propylene glycol solution/drops
  • Fort Worth, Texas
    Alcon Call Center for Trial Locations
Jun 5, 2023

Myopia Trial in Assiut (Preservative-free Benoxinate HCl 0.4% (Benoxidia unit-dose vials [UD], Orchidia pharmaceutical Ind.,

Completed
  • Myopia
  • Preservative-free Benoxinate hydrochloride 0.4% (Benoxidia unit-dose vials [UD], Orchidia pharmaceutical Ind., Egypt)
  • Preservative-free Sodium hyaluronate 0.2% (Polyfresh unit-dose vials [UD], Orchidia pharmaceutical Ind., Egypt).
  • Assiut, Egypt
    Tiba Eye Center
Feb 8, 2023

Dry Eye Trial in Fort Worth (Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF), Polyethylene

Not yet recruiting
  • Dry Eye
  • Polyethylene glycol 400 and propylene glycol solution/drops - Preservative Free (PF)
  • Polyethylene glycol 400 and propylene glycol solution/drops - Preserved
  • Fort Worth, Texas
    Alcon Call Center for Trial Locations
Jul 6, 2023

Preservative-Free Ophthalmic Solution in Ocular Dryness

Active, not recruiting
  • Dry Eye Syndromes
  • Eyestil SYNFO
  • Alicante, Spain
  • +3 more
Mar 20, 2023

Ocular Redness Trial in United States (Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation, Lumify®

Recruiting
  • Ocular Redness
  • Brimonidine tartrate ophthalmic solution 0.025% preservative-free formulation
  • Lumify® (brimonidine tartrate ophthalmic solution 0.025%)
  • Colorado Springs, Colorado
  • +5 more
Oct 3, 2022

Effect of Drug Trial in Lagos (Latanoprost 0.005% Ophthalmic Solution)

Recruiting
  • Effect of Drug
  • Latanoprost 0.005% Ophthalmic Solution
  • Lagos, Lagos State, Nigeria
    Guinness Eye Centre. Lagos University Teaching Hospital.
Nov 1, 2022

Glaucoma, Ocular Hypertensive Trial in Seoul (BRIDIN-plus Eye drops, Combigan Eye drops)

Completed
  • Glaucoma
  • Ocular Hypertensive
  • BRIDIN-plus Eye drops
  • Combigan Eye drops
  • Seoul, Seongnam, Bundang-gu, Korea, Republic of
    Seungsoo Rho
Oct 9, 2023

Influenza Trial in India (Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative, Quadrivalent

Completed
Has Results
  • Influenza
  • Quadrivalent Inactivated Influenza Vaccine (2016-2017 NH formulation), No Preservative
  • +3 more
  • Vadodara, Gujarat, India
  • +7 more
Mar 24, 2022

Dry Eye Syndromes, Cataract Trial in Haugesund (Lubricant Eye Drops, Preservative Free, Preservative)

Recruiting
  • Dry Eye Syndromes
  • Cataract
  • Lubricant Eye Drops
  • +2 more
  • Haugesund, Norway
    Ifocus øyeklinikk
Jun 21, 2022

Chronic Migraine, Headache Trial in Syracuse (Preserved saline in reconstitution of Botox)

Completed
Has Results
  • Chronic Migraine, Headache
  • Preserved saline in reconstitution of Botox
  • Syracuse, New York
    SUNY Upstate Medical University
May 8, 2022

Pain Trial in Cleveland (Preservative free morphine, Fentanyl)

Completed
  • Pain
  • Cleveland, Ohio
    University Hospitals Case Medical Center
Mar 14, 2022

Postpartum Pain, Postpartum Depression, Opioid Consumption Trial in New York (Preservative Free Morphine, Saline)

Enrolling by invitation
  • Postpartum Pain
  • +2 more
  • Preservative Free Morphine
  • Saline
  • New York, New York
    Mount Sinai Hospital
Dec 16, 2021

Preservative-free Fixed-dose Combination of Tafluprost 0.0015% /

Completed
  • Ocular Surface Disease
  • Primary Open Angle Glaucoma
  • Tafluprost, timolol maleate
  • Taoyuan city, Taiwan
    Chang-Geng Medical Foundation Linkou Chang-Geng Memorial Hospita
Oct 27, 2022

Primary Open Angle Glaucoma (POAG), Primary Open Angle Glaucoma of Both Eyes, Primary Open-Angle Glaucoma, Unspecified Eye Trial

Not yet recruiting
  • Primary Open Angle Glaucoma (POAG)
  • +3 more
  • Experimental: QLS-111 ophthalmic solution, (0.015%)
  • +4 more
  • (no location specified)
Aug 30, 2023

Dry Eye Trial in United States (Investigational Lubricating Eye Drop in a Novelia® bottle, Blink® Tears eye Drops)

Not yet recruiting
  • Dry Eye
  • Investigational Lubricating Eye Drop in a Novelia® bottle
  • Blink® Tears eye Drops
  • Jacksonville, Florida
  • +7 more
Jan 23, 2023

Influenza, Influenza, Human, Influenza Viral Infections Trial in Russian Federation (Influenza vaccine [inactivated])

Completed
  • Influenza
  • +4 more
  • Influenza vaccine [inactivated]
  • Kol'tsovo, Novosibirsk Region, Russian Federation
  • +4 more
May 11, 2023

Bladder Cancer Trial in Erlangen (other, radiation, drug)

Recruiting
  • Bladder Cancer
  • Hyperthermia
  • +3 more
  • Erlangen, Germany
    Dept. of Radiation Therapy, University Hospital Erlangen
May 25, 2022

Normal Tension Glaucoma Trial in Sioux Falls (QLS-101)

Completed
  • Normal Tension Glaucoma
  • Sioux Falls, South Dakota
    Vance Thompson Vision
Oct 7, 2022

Pain Trial in Brooklyn (Preservative Free Lidocaine, Saline)

Recruiting
  • Pain
  • Preservative Free Lidocaine
  • Saline
  • Brooklyn, New York
    Maimonides Medical Center
Jan 31, 2023

Neuropathic Pain Trial in Winston-Salem (oxytocin 100 micrograms, Normal Saline (preservative free))

Terminated
  • Neuropathic Pain
  • oxytocin 100 micrograms
  • Normal Saline (preservative free)
  • Winston-Salem, North Carolina
    Wake Forest School of Medicine
Dec 4, 2022

Blepharoptosis, Synkinesis, Hyperkinesis Trial in Hershey (Oxymetazoline 0.1% (Pf) Oph Soln Ud, Preservative free lubricating

Not yet recruiting
  • Blepharoptosis
  • +3 more
  • Oxymetazoline 0.1% (Pf) Oph Soln Ud
  • Preservative free lubricating drops
  • Hershey, Pennsylvania
    M.S. Hershey Medical Center
Jul 6, 2023

Dry Eye Syndromes, Diabetic Retinopathy, Oxidative Stress Trial in Guadalajara (VisuXL®, Lagricel PF®, Humylub PF®)

Recruiting
  • Dry Eye Syndromes
  • +3 more
  • Guadalajara, Jalisco, Mexico
    Institute of Experimental and Clinical Therapeutics,
Jun 23, 2022

Pain Reduction Trial (1% preservative-free lidocaine, Phenylephrine 1.0%/ Ketorolac 0.3%)

Withdrawn
  • Pain Reduction
  • 1% preservative-free lidocaine
  • Phenylephrine 1.0%/ Ketorolac 0.3%
  • (no location specified)
Jun 9, 2022

Ocular Surface Disease, Glaucoma Trial in Campobasso (Hydrocortisone (CORTIVIS ®))

Completed
  • Ocular Surface Disease
  • Glaucoma
  • Hydrocortisone (CORTIVIS ®)
  • Campobasso, Italy
    University of Molise
Sep 30, 2021